Seyedkazemi Setareh
SEC insider (Form 3/4/5 filer). CIK 0001903088. CHIEF DEVELOPMENT OFFICER at Adverum Biotechnologies, Inc. (ADVM). 18 reported Form 4/5 transactions since Sep 2024; latest on Dec 9, 2025. Located in REDWOOD CITY, CA.
Companies Seyedkazemi Setareh has filed insider reports for
- Adverum Biotechnologies, Inc. (ADVM): Officer, CHIEF DEVELOPMENT OFFICER
Seyedkazemi Setareh
CIK: 0001903088
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Adverum Biotechnologies, Inc.
Discretionary Trading P&L
Holdings
Transaction History (18 total)
- Dec 9, 2025ADVM
Adverum Biotechnologies, Inc.
Tender OfferDirect54.9K shares- - Dec 9, 2025ADVM
Adverum Biotechnologies, Inc.
Tender OfferDirect8.1K shares- - Dec 9, 2025ADVM
Adverum Biotechnologies, Inc.
AwardDirect85K shares- - Dec 9, 2025ADVM
Adverum Biotechnologies, Inc.
Tender OfferDirect88.3K shares- - Dec 9, 2025ADVM
Adverum Biotechnologies, Inc.
DispositionDirectStock Option (Right to Buy)
40K shares- - Dec 9, 2025ADVM
Adverum Biotechnologies, Inc.
DispositionDirectStock Option (Right to Buy)
42.5K shares- - Dec 9, 2025ADVM
Adverum Biotechnologies, Inc.
DispositionDirectStock Option (Right to Buy)
8.5K shares- - Dec 9, 2025ADVM
Adverum Biotechnologies, Inc.
DispositionDirectStock Option (Right to Buy)
25K shares- - Dec 9, 2025ADVM
Adverum Biotechnologies, Inc.
DispositionDirectStock Option (Right to Buy)
43.5K shares- - Dec 9, 2025ADVM
Adverum Biotechnologies, Inc.
DispositionDirectStock Option (Right to Buy)
48.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | Tender Offer | 54,874 | - | - | Direct |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | Tender Offer | 8,125 | - | - | Direct |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | Award | 85,000 | - | - | Direct |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | Tender Offer | 88,332 | - | - | Direct |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | Disposition Stock Option (Right to Buy) | 40,000 | - | - | Direct |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | Disposition Stock Option (Right to Buy) | 42,500 | - | - | Direct |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | Disposition Stock Option (Right to Buy) | 8,500 | - | - | Direct |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | Disposition Stock Option (Right to Buy) | 25,000 | - | - | Direct |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | Disposition Stock Option (Right to Buy) | 43,458 | - | - | Direct |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | Disposition Stock Option (Right to Buy) | 48,750 | - | - | Direct |
1-10 of 18 transactions